General Information of Drug (ID: DMN8OR2)

Drug Name
Piperidin-(2E)-ylideneamine Drug Info
Synonyms
PIPERIDIN-2-IMINE; 2-Piperidinimine; Piperidin-(2E)-ylideneamine; Piperidin-(2Z)-ylideneamine; CHEMBL269058; 2-amino-4-piperidyl; 22780-54-7; EN300-77982; 2-iminopiperidine; 2IM; AMINOPIPERIDINYL; NCGC00024898-01; Tocris-0951; (2E)-piperidin-2-imine; 2-Iminopiperidine, Hydrochloride; CTK0J6105; DTXSID40275816; DHGUMNJVFYRSIG-UHFFFAOYSA-N; 3,4,5,6-tetrahydropyridine amine; ZINC2141055; AC1L3920; BDBM50049255; 2,3,4,5-tetrahydropyridin-6-amine; 3,4,5,6-Tetrahydropyridin-2-amine; AKOS005199122; AKOS002684133; MCULE-9735306041
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
85237
CAS Number
CAS 22780-54-7
TTD Drug ID
DMN8OR2

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Nitric-oxide synthase brain (NOS1) TTZUFI5 NOS1_HUMAN Inhibitor [1]
Nitric-oxide synthase endothelial (NOS3) TTCM4B3 NOS3_HUMAN Inhibitor [1]
Nitric-oxide synthase inducible (NOS2) TTF10I9 NOS2_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Nitric-oxide synthase brain (NOS1) DTT NOS1 6.085 5.844 5.849 5.806
Nitric-oxide synthase inducible (NOS2) DTT NOS2 4.95 5.198 4.573 5.121
Nitric-oxide synthase endothelial (NOS3) DTT NOS3 4.787 4.154 5.133 3.053
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Nitric-oxide synthase inducible (NOS2) DTT NOS2 4.24E-02 -0.27 -0.88
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inh... Bioorg Med Chem Lett. 2005 Apr 15;15(8):1997-2001.